Sign Up to like & get
recommendations!
0
Published in 2020 at "Contraception"
DOI: 10.1016/j.contraception.2020.05.004
Abstract: OBJECTIVE To evaluate serum estradiol (E2) concentrations during use of 90-day contraceptive vaginal rings releasing E2 75, 100, or 200 mcg/day and segesterone acetate (SA) 200 mcg/day to identify a dose that avoids hypoestrogenism. Study…
read more here.
Keywords:
segesterone acetate;
200 mcg;
mcg day;
contraceptive vaginal ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "Contraception"
DOI: 10.1016/j.contraception.2021.03.024
Abstract: OBJECTIVE To predict serum segesterone (SA) and ethinyl estradiol (EE) levels after 364 days of hypothetical continuous use (without removal) of a cyclic contraceptive vaginal system (CVS) containing 0.15 mg SA and 0.013 mg EE.…
read more here.
Keywords:
segesterone acetate;
use;
cvs;
serum ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "Fertility and Sterility"
DOI: 10.1016/j.fertnstert.2019.07.163
Abstract: Author(s): Archer, David F; Barnhart, Kurt T; Nelson, Anita L; Creinin, Mitchell D; Jensen, Jeffrey T; Mirkin, Sebastian; Merkatz, Ruth B
read more here.
Keywords:
segesterone acetate;
patterns endometrial;
year segesterone;
safety year ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2023 at "Journal of women's health"
DOI: 10.1089/jwh.2022.0264
Abstract: Background: We evaluated satisfaction with use of a segesterone acetate and ethinyl estradiol (0.15/0.013 mg) contraceptive vaginal system (CVS) among women who had recently used a monthly contraceptive vaginal ring or contraceptive pills. The CVS is…
read more here.
Keywords:
contraceptive vaginal;
acetate ethinyl;
segesterone acetate;
ring ... See more keywords